Brief: Rosetta Genomics says plans to introduce oncogxone, Admera Health's NGS panel
25/03/2015 12:03
March 25 (Reuters) - Rosetta Genomics Ltd ROSG.O : * Says plans to introduce oncogxone, Admera Health's next-generation sequencing (NGS) panel * Oncogxone detects genetic alterations implicated in cancer to provide clinical recommendations from single, comprehensive test * Source text for Eikon ID:nBwbyXlV1a * Further company coverage ROSG.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics